TABLE 2.
Zones of inhibition of M. neoaurum isolated from patients with catheter-related bacteremia
| Antibiotic | Zone diameter (mm) for isolate from patient:
|
||
|---|---|---|---|
| 1 | 2 | 4 | |
| Ampicillin | 30 | ||
| Amoxicillin | 18 | ||
| Amoxicillin-clavulanate | 45 | ||
| Cefazolin | 16 | ||
| Cefuroxime | 15 | ||
| Cefoxitin | ≥30 | ≥30 | 23 |
| Enoxacin | ≥30 | ||
| Cefotaxime | 6 | ||
| Ceftazidime | 6 | ||
| Ticarcillin-clavulanate | ≥30 | ||
| Imipenem | ≥30 | ≥30 | 48 |
| Meropenem | 41 | ||
| Erythromycin | ≥30 | 16 | |
| Clarithromycin | ≥30 | 24 | |
| Roxithromycin | ≥30 | ||
| Azithromycin | ≥30 | ||
| Vancomycin | ≥30 | ||
| Ofloxacin | 52 | ||
| Ciprofloxacin | ≥30 | 60 | |
| Amikacin | ≥30 | ≥30 | 45 |
| Tobramycin | 25 | 23 | |
| Gentamicin | ≥30 | ||
| Kanamycin | ≥30 | ||
| Tetracycline | ≥30 | ≥30 | 55 |
| Doxycycline | ≥30 | 65 | |
| Minocycline | ≥30 | ||
| Co-trimoxazole | ≥30 | <20 | 35 |